Pharmacokinetic (PK) and Pharmacodynamic (PD) Analyses
PK/PD analyses and exploratory study support to evaluate oncology drug effects.
PK Study Support
PK Support for Oncology Trials
Theradex has a long history of experience in providing support for pharmacokinetic (PK) studies for early phase oncology clinical trials across a wide range of compounds and biologics. Our in-house team of scientific (PhD), biostatistic and project management experts have experience in delivering all key components of a successful PK report which include:
- PK vendor identification, due diligence and management
- Scientific review of electronic data capture design
- Site management
- Clinical data review and reconciliation
- Statistical tables, listings and files of PK concentration and parameter datasets
- Scientific review of interim and final PK reports
Exploratory Study Expertise
Exploratory Trial Support
Our in-house team of scientific (PhD) and project management experts will help design your study to maximize exploratory and pharmacodynamic endpoints.
Theradex will provide guidance in:
- Scientific review of electronic data capture design
- Regulatory issues
- Site management
- Data transfer
- Clinical data review and reconciliation
- Vendor identification, due diligence and management
- Scientific review of interim and final data reports
- Statistical tables, listings and files